BNIP3L
BNIP3L (BCL2 interacting protein 3 like), also known as Nix or BNIP3a, is a pro-apoptotic member of the Bcl-2 family that targets mitochondria. It induces apoptosis and contributes to mitochondrial quality control. Browse Assay Genie's current range of BNIP3L research reagents below, or read on for the biology behind the target.
BNIP3L is a pro-apoptotic protein that induces apoptosis and interacts with viral and cellular anti-apoptosis proteins. According to the NCBI Gene summary, it belongs to the pro-apoptotic subfamily within the Bcl-2 family, binds Bcl-2 and carries a BH3 domain. The protein targets mitochondria directly and causes apoptotic changes, including loss of membrane potential and release of cytochrome c. It can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. It also inhibits apoptosis induced by BNIP3.
Beyond cell death, BNIP3L is involved in mitochondrial quality control through its interaction with SPATA18/MIEAP. In response to mitochondrial damage, it takes part in a mitochondrial protein catabolic process (also called MALM) that leads to degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane, which mediates translocation of lysosomal proteins from the cytoplasm into the mitochondrial matrix.
The BNIP3L gene encodes a protein of the NIP3 family. UniProt records its location at the mitochondrion outer membrane, the endoplasmic reticulum and the nuclear envelope. The protein is also known as Nix and BNIP3a, and the mouse ortholog is Bnip3l. The HGNC name, BCL2 interacting protein 3 like, reflects its relationship to BNIP3, and UniProt notes that BNIP3L may function as a tumour suppressor.
BNIP3L induces apoptosis, can overcome BCL-2 and BCL-XL suppression, and is a model pro-apoptotic Bcl-2 family member.
With SPATA18/MIEAP and BNIP3, BNIP3L helps degrade damaged mitochondrial proteins and regulates a pore in the mitochondrial double membrane.
BNIP3L binds Bcl-2 through its BH3 domain, making it useful for studying interactions between pro- and anti-apoptotic proteins.
UniProt notes BNIP3L may function as a tumour suppressor, linking mitochondrial cell death regulation to cancer biology.
BNIP3L induces apoptosis by targeting mitochondria, where it causes loss of membrane potential and cytochrome c release. It also contributes to mitochondrial quality control with SPATA18/MIEAP and BNIP3, and may act as a tumour suppressor.
BNIP3L is also called Nix and BNIP3a. Its previous name was BCL2/adenovirus E1B 19kDa interacting protein 3 like. UniProt lists the protein as BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like, a member of the NIP3 family.
BNIP3L inhibits apoptosis induced by BNIP3, yet the two proteins interact with SPATA18/MIEAP at the mitochondrial outer membrane. A mouse ortholog, Bnip3l, exists; check the datasheet of any product for its validated reactivity.
Other BNIP proteins and Bcl-2 family apoptosis regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O60238; product specifications from Assay Genie datasheets.